Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.30 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2963352 | 0.92 | ALDH1A1 (0.42) | LMNA | |
| SCHEMBL6556363 | 0.90 | LMNA (0.36) | LMNAESR1ESR2CA1CA2 | |
| SCHEMBL6048383 | 0.90 | LMNA (0.36) | LMNAESR1ESR2CA1CA2 | |
| SCHEMBL7138748 | 0.88 | CA1 (0.41) | LMNACA1CA2 | |
| SCHEMBL24871109 | 0.88 | LMNA (0.35) | LMNA | |
| SCHEMBL24870926 | 0.88 | LMNA (0.35) | LMNANR1H2NR1H3 | |
| SCHEMBL24870976 | 0.88 | LMNA (0.35) | LMNA | |
| SCHEMBL11217955 | 0.88 | TSHR (0.42) | LMNACA1CA2 | |
| SCHEMBL1119523 | 0.88 | LMNA (0.35) | LMNA | |
| SCHEMBL25056725 | 0.88 | PDE2A (0.35) | LMNACA1CA2NR1H2NR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9156938-B2 | Compositions, methods, and systems comprising fluorous-soluble polymers | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2015-10-13 | — | — | US | disclosed |
| US-20120177578-A1 | COMPOSITIONS, METHODS, AND SYSTEMS COMPRISING FLUOROUS-SOLUBLE POLYMERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2012-07-12 | — | — | US | disclosed |
| WO-2012024592-A2 | COMPOSITIONS, METHODS, AND SYSTEMS COMPRISING FLUOROUS-SOLUBLE POLYMERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2012-02-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120177578-A1 | COMPOSITIONS, METHODS, AND SYSTEMS COMPRISING FLUOROUS-SOLUBLE POLYMERS | NAF1, PFAS, MALT1 | LMNA 1126/4885ESR1 429/4885ESR2 2404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.